Prostate cancer is a type of cancer that affects a lot of men, and as there is no cure for cancer yet, spotting the symptoms is important. One of the possible indicators of the disease is through another condition, according to a new report.
Express reports that jaundice may also be a possible symptom of prostate cancer among men. Jaundice is referred to as having a yellowish tinge in the skin, as well as the whites of the eyes. This is caused by issues with the liver, and this condition would mean that the cancer has already progressed and spread towards the liver, where there may be some problems with the bile duct or large parts of the liver that have already been affected.
Jaundice is not the only indication that the cancer has already affected the liver. Other indicators include a pain on the right side of the body, nausea, loss of appetite, weight loss, itchy skin, as well as a swollen tummy.
Another possible indicator of prostate cancer is found in the urine. Express also reports that seeing a pink, red, or brownish-red color in the urine may be a symptom of prostate cancer. This would mean that there is blood. The same applies if there is blood in the semen, as the prostate is responsible for the production of semen, the fluid that is carrying the sperm. According to Cancer News Today, finding blood in the urine is also known as hematuria, and it can indicate that the prostate cancer has progressed.
However, because these are merely symptoms, there is a big chance that it may indicate other conditions that are not as severe as prostate cancer. Still, in case these are seen, then it is highly advised to consult a doctor to get a proper diagnosis and treatment. The earlier this is detected, the more successful treatment will be.
Prostate cancer mainly affects men above the age of 50, and the usual time of diagnosis between men is from 65 to 69. The risk of developing prostate cancer increases among men if there is a family history of either prostate or breast cancer.


AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak
NIH Infectious Disease Leadership Shake-Up Raises Concerns Amid Ebola, Hantavirus Outbreaks
UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations
France Keeps Top Health Alert as Officials Brace for Another Heatwave
3 clinical-grade skincare creams you really shouldn’t buy online
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
France Battles Mediterranean Wildfires as Heatwave Fuels Fire Risk
Venezuela Earthquake Health Risks Rise as Disease Monitoring Intensifies
FDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to Rise
Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race 



